Rice, S., Gleeson, J., Davey, C. G, Hetrick, S., Parker, A., Lederman, R., Wadley, G., Murray, G., Herrman, H., Chambers, R., Russon, P., Miles, C., D'Alfonso, S., Thurley, M., Chinnery, G., Gilbertson, T., Eleftheriadis, D., Barlow, E., Cagliarini, D., Toh, J., Mcalpine, S., Koval, P., Bendall, S., Jansen, J. E, Hamilton, M., McGorry, P. & Alvarez-Jimenez, M. (2016). Moderated online social therapy for depression relapse prevention in young people: Pilot study of a 'next generation' online intervention. Early Intervention in Psychiatry, 1-13. Australia: Blackwell Publishing. Retrieved from https://doi.org/10.1111/eip.12354
Aim: Implementation of targeted e-mental health interventions offers a promising solution to reducing the burden of disease associated with youth depression. A single-group pilot study was conducted to evaluate the acceptability, feasibility, usability and safety of a novel, moderated online social therapy intervention (entitled Rebound) for depression relapse prevention in young people. Methods: Participants were 42 young people (15–25 years) (50% men; mean age = 18.5 years) in partial or full remission. Participants had access to the Rebound platform for at least 12 weeks, including the social networking, peer and clinical moderator and therapy components. Results: Follow-up data were available for 39 (92.9%) participants. There was high system usage, with 3034 user logins (mean = 72.2 per user) and 2146 posts (mean = 51.1). Almost 70% of users had ≥10 logins over the 12 weeks, with 78.5% logging in over at least 2 months of the pilot. A total of 32 (84%) participants rated the intervention as helpful. There was significant improvement between the number of participants in full remission at baseline (n = 5; none of whom relapsed) relative to n = 19 at 12-week follow-up (P < 0.001). Six (14.3%) participants relapsed to full threshold symptoms at 12 weeks. There was a significant improvement to interviewer-rated depression scores (Montgomery–Asberg Depression Rating Scale (MADRS); P = 0.014, d = 0.45) and a trend for improved strength use (P = 0.088, d = 0.29). The single-group design and 12-week treatment phase preclude a full understanding of the clinical benefits of the Rebound intervention. Conclusions: The Rebound intervention was shown to be acceptable, feasible, highly usable and safe in young people with major depression.
Access may be restricted.